Abstract：Objective To explore the relationship of gestational diabetes and serum retinal omentin-1.Methods Two hundred cases delivered in our hospital during June 2011 to October 2012 were selected, with one hundred being normal women (NGT group), and one hundred being women with gestational diabetes (GDM group). Retinal omentin-1 in venous blood and cord blood of both groups were tested by enzyme-linked immunosorbent assay (ELISA).Results The level of retinal omentin-1 in both venous blood [(8.3±3.8)μg/L],and cord blood [(13.6±6.1)μg/L] of GDM group was significantly lower than that of NGT group [(23.8±11.1)μg/L and (25.5±7.5)μg/L, respectively].Conclusion The level of retinal omentin-1 was significantly lower in GDM cases than in healthy women.
杨芳, 韦瑞红, 曾晓娟, 何春容, 刘小乐, 张仙. 新脂肪因子网膜素-1与妊娠期糖尿病的相关性[J]. 中国生育健康杂志, 2014, 25(5): 403-404.
Department of Gynecology and Obstetrics, The Fourth People Hospital of Shenzhen, Shenzhen 518000, China. Correlation of gestational diabetes and new fat factor retinal omentin-1. Chinese Journal of Reproductive Health, 2014, 25(5): 403-404.
1 乐杰.妇产科学.北京:人民卫生出版社,2008:150. 2 金富剑.糖尿病患者合并妊娠应用胰岛素的治疗与观察体会.中国社区医师(医学专业),2010,12:88-89. 3 Kral Kralisch S,Klein J,Bluher M,et al.Therapeutic perspectives of adipocytokines.Expert Opin Pharmacother,2005,6:863-872. 4 张秀娟,刘礼斌.新型脂肪细胞因子网膜素的研究进展.医学前沿,2011,40:26-28. 5 Schaffler A,Neumeier M,Herfarth H,et al.Genomicstructure of human omentin,a new adipocytokine expressedin omental adipose tissue.Biochim Biophys Acts,2005,1732:96-102. 6 Zhang F,Dong L,Zhang CP,et al.Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008.Diabet Med,2011,28:652-657. 7 宋耕,杨慧霞.妊娠期糖尿病对其母儿远期转归的影响.中华糖尿病杂志,2012,4:245-247. 8 Yang RZ,Lee MJ,Hu H,et al.Identification of omentin as novel depot·specific adipekine in human adipose tissue:possible role in modulating insulin action.Am J Physiol Endocrinol Metab,2006,290:E1253-E1261. 9 龚磊,白波,陈京.网膜素:一个新的脂肪因子.生理科学进展,2011,42:390-393. 10 Pan HY,Guo L,Li Q.Changes of serum omentin-l levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.Diabetes Res Clin Pract,2010,88:29-33.
